Reduced Adult Neurogenesis and Altered Emotional Behaviors in Autoimmune-Prone B-Cell Activating Factor Transgenic Mice

Biological Psychiatry

Volumn 67, Issue 6, 2010, Pages 558-566

  Crupi, Rosalia ^a   Cambiaghi, Marco ^a   Spatz, Linda ^a   Hen, René ^b   Thorn, Mitchell ^a   Friedman, Eitan ^a   Vita, Giuseppe ^c   Battaglia, Fortunato ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Anxiety; autoimmune CNS diseases; BAFF; hippocampus; neurogenesis

Indexed keywords

B CELL ACTIVATING FACTOR; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; EMOTIONAL DISORDER; ENCEPHALITIS; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; MENTAL STRESS; MOOD DISORDER; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; STEM CELL; STIMULUS RESPONSE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENIC MOUSE;

AGE FACTORS; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANXIETY; B-CELL ACTIVATING FACTOR; BEHAVIOR, ANIMAL; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EMOTIONS; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HINDLIMB SUSPENSION; HIPPOCAMPUS; IMMUNOGLOBULIN G; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NEUROGENESIS; NEURONS; NEUROPEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; STEM CELLS; SWIMMING;

EID: 76849091900     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.12.008     Document Type: Article

References (64)

1. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58 (2001) 445-452
2. Konsman J.P., Parnet P., and Dantzer R. Cytokine-induced sickness behaviour: Mechanisms and implications. Trends Neurosci 25 (2002) 154-159
3. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34 (1995) 301-309
4. Nery F.G., Borba E.F., Hatch J.P., Soares J.C., Bonfa E., and Neto F.L. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry 48 (2007) 14-19
5. Minden S.L., and Schiffer R.B. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 47 (1990) 98-104
6. Mohr D.C., Dick L.P., Russo D., Pinn J., Boudewyn A.C., Likosky W., et al. The psychosocial impact of multiple sclerosis: Exploring the patient's perspective. Health Psychol 18 (1999) 376-382
7. Mackay F., Sierro F., Grey S.T., and Gordon T.P. The BAFF/April system: An important player in systemic rheumatic diseases. Curr Dir Autoimmun 8 (2005) 243-265
8. Bosello S., Pers J.O., Rochas C., Devauchelle V., De Santis M., Daridon C., et al. BAFF and rheumatic autoimmune disorders: Implications for disease management and therapy. Int J Immunopathol Pharmacol 20 (2007) 1-8
9. Krumbholz M., Specks U., Wick M., Kalled S.L., Jenne D., and Meinl E. BAFF is elevated in serum of patients with Wegener's granulomatosis. J Autoimmun 25 (2005) 298-302
10. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201 (2005) 195-200
11. Huntington N.D., Tomioka R., Clavarino C., Chow A.M., Linares D., Mana P., et al. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses. Int Immunol 18 (2006) 1473-1485
12. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 (1999) 1697-1710
13. Groom J.R., Fletcher C.A., Walters S.N., Grey S.T., Watt S.V., Sweet M.J., et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 204 (2007) 1959-1971
14. Benkovic S.A., O'Callaghan J.P., and Miller D.B. Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice. Brain Res 1070 (2006) 215-231
15. Grider M.H., Chen Q., and Shine H.D. Semi-automated quantification of axonal densities in labeled CNS tissue. J Neurosci Methods 155 (2006) 172-179
16. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
17. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
18. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
19. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
20. Linden A.M., Baez M., Bergeron M., and Schoepp D.D. Increased c-Fos expression in the centromedial nucleus of the thalamus in metabotropic glutamate 8 receptor knockout mice following the elevated plus maze test. Neuroscience 121 (2003) 167-178
21. Franklin K. Mouse Brain in Stereotaxic Coordinates Vol. 2E (1997), Academic Press, San Diego, CA
22. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
23. Saxe M.D., Battaglia F., Wang J.W., Malleret G., David D.J., Monckton J.E., et al. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc Natl Acad Sci U S A 103 (2006) 17501-17506
24. Wang J.W., David D.J., Monckton J.E., Battaglia F., and Hen R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 28 (2008) 1374-1384
25. Snyder J.S., Kee N., and Wojtowicz J.M. Effects of adult neurogenesis on synaptic plasticity in the rat dentate gyrus. J Neurophysiol 85 (2001) 2423-2431
26. Gordon S., Lawson L., Rabinowitz S., Crocker P.R., Morris L., and Perry V.H. Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol 181 (1992) 1-37
27. Malinow K.L., Molina R., Gordon B., Selnes O.A., Provost T.T., and Alexander E.L. Neuropsychiatric dysfunction in primary Sjogren's syndrome. Ann Intern Med 103 (1985) 344-350
28. Andonopoulos A.P., Lagos G., Drosos A.A., and Moutsopoulos H.M. Neurologic involvement in primary Sjogren's syndrome: A preliminary report. J Autoimmun 2 (1989) 485-488
29. Brey R.L., Stallworth C.L., McGlasson D.L., Wozniak M.A., Wityk R.J., Stern B.J., et al. Antiphospholipid antibodies and stroke in young women. Stroke 33 (2002) 2396-2400
30. Valtysdottir S.T., Gudbjornsson B., Lindqvist U., Hallgren R., and Hetta J. Anxiety and depression in patients with primary Sjogren's syndrome. J Rheumatol 27 (2000) 165-169
31. Janssens A.C., van Doorn P.A., de Boer J.B., van der Meche F.G., Passchier J., and Hintzen R.Q. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 108 (2003) 389-395
32. Burman M.E., McCabe S., and Pepper C.M. Treatment practices and barriers for depression and anxiety by primary care advanced practice nurses in Wyoming. J Am Acad Nurse Pract 17 (2005) 370-380
33. Rostron J., Rogers S., Longman L., Kaney S., and Field E.A. Health-related quality of life in patients with primary Sjogren's syndrome and xerostomia: A comparative study. Gerodontology 19 (2002) 53-59
34. Sakic B., Szechtman H., Talangbayan H., Denburg S.D., Carbotte R.M., and Denburg J.A. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav 56 (1994) 609-617
35. Schrott L.M., and Crnic L.S. Anxiety behavior, exploratory behavior, and activity in NZB x NZW F1 hybrid mice: Role of genotype and autoimmune disease progression. Brain Behav Immun 10 (1996) 260-274
36. Sakic B., Szechtman H., and Denburg J.A. Neurobehavioral alterations in autoimmune mice. Neurosci Biobehav Rev 21 (1997) 327-340
37. Ballok D.A. Neuroimmunopathology in a murine model of neuropsychiatric lupus. Brain Res Rev 54 (2007) 67-79
38. Dean G.S., Tyrrell-Price J., Crawley E., and Isenberg D.A. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 59 (2000) 243-251
39. Tomita M., Holman B.J., and Santoro T.J. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett 302 (2001) 129-132
40. Lawrence D.A., Bolivar V.J., Hudson C.A., Mondal T.K., and Pabello N.G. Antibody induction of lupus-like neuropsychiatric manifestations. J Neuroimmunol 182 (2007) 185-194
41. Mondal T.K., Saha S.K., Miller V.M., Seegal R.F., and Lawrence D.A. Autoantibody-mediated neuroinflammation: Pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model. Brain Behav Immun (2008)
42. Duncan G.E., Knapp D.J., and Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res 713 (1996) 79-91
43. Salome N., Salchner P., Viltart O., Sequeira H., Wigger A., Landgraf R., et al. Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): Differential Fos expression in HAB and LAB rats. Biol Psychiatry 55 (2004) 715-723
44. Gould E., McEwen B.S., Tanapat P., Galea L.A., and Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17 (1997) 2492-2498
45. Gould E., Beylin A., Tanapat P., Reeves A., and Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2 (1999) 260-265
46. Drew M.R., and Hen R. Adult hippocampal neurogenesis as target for the treatment of depression. CNS Neurol Disord Drug Targets 6 (2007) 205-218
47. Sakic B., Kirkham D.L., Ballok D.A., Mwanjewe J., Fearon I.M., Macri J., et al. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J Neuroimmunol 169 (2005) 68-85
48. Overstreet-Wadiche L.S., Bensen A.L., and Westbrook G.L. Delayed development of adult-generated granule cells in dentate gyrus. J Neurosci 26 (2006) 2326-2334
49. Wang S., Scott B.W., and Wojtowicz J.M. Heterogenous properties of dentate granule neurons in the adult rat. J Neurobiol 42 (2000) 248-257
50. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189 (1999) 1747-1756
51. Schmidt-Hieber C., Jonas P., and Bischofberger J. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature 429 (2004) 184-187
52. Overstreet L.S. Quantal transmission: Not just for neurons. Trends Neurosci 28 (2005) 59-62
53. Barkus C., McHugh S.B., Sprengel R., Seeburg P.H., Rawlins J.N., and Bannerman D.M. Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion. Eur J Pharmacol 626 (2010) 49-56
54. Das S., and Basu A. Inflammation: A new candidate in modulating adult neurogenesis. J Neurosci Res 86 (2008) 1199-1208
55. Jakubs K., Bonde S., Iosif R.E., Ekdahl C.T., Kokaia Z., Kokaia M., et al. Inflammation regulates functional integration of neurons born in adult brain. J Neurosci 28 (2008) 12477-12488
56. Tancredi V., D'Arcangelo G., Grassi F., Tarroni P., Palmieri G., Santoni A., et al. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146 (1992) 176-178
57. Cumiskey D., Butler M.P., Moynagh P.N., and O'Connor J.J. Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation. Brain Res 1136 (2007) 13-19
58. Cacci E., Claasen J.H., and Kokaia Z. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J Neurosci Res 80 (2005) 789-797
59. Widera D., Mikenberg I., Elvers M., Kaltschmidt C., and Kaltschmidt B. Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling. BMC Neurosci 7 (2006) 64
60. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7 (2001) 1189-1193
61. Kowal C., Degiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 103 (2006) 19854-19859
62. Morimoto K., Katayama K., Inoue K., and Sato K. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Pharmacol Biochem Behav 40 (1991) 893-899
63. Nacher J., and McEwen B.S. The role of N-methyl-D-asparate receptors in neurogenesis. Hippocampus 16 (2006) 267-270
64. Ge S., Yang C.H., Hsu K.S., Ming G.L., and Song H. A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain. Neuron 54 (2007) 559-566